Akeso Reports Phase 3 Trials Show Positive Results: Gumokimab (IL-17) for Ankylosing Spondylitis and Manfidokimab (IL-4Rα) for Atopic Dermatitis Achieve Primary Endpoints
HONG KONG, Aug. 25, 2025 /PRNewswire/ — Akeso Inc. (9926.HK) (“Akeso” or “the Company”) today announced positive results from its Phase... Read more.
Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts
EAST RUTHERFORD, N.J., Aug. 25, 2025 /PRNewswire/ — Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced that... Read more.
EFSIM Secures Strategic Contract Awards with Value Over SAR 750 million in H1 2025, Driving Growth Across Key Sectors
Significant contract awards reaffirm EFSIM leadership in Saudi Arabia’s facilities management sector The company continued to expand its presence in high-growth... Read more.
Government of Odisha and GFTN Launch BharatNetra Initiative to Establish Integrated Global Financial Technology Capability Hub in Bhubaneswar
BHUBANESWAR, India, Aug. 24, 2025 /PRNewswire/ — The Government of Odisha, in collaboration with the Singapore-headquartered Global Finance & Technology... Read more.
Golfin Welcomes MEXC as Title Sponsor of “MEXC Ventures Global Golf Masters supported by GOLFIN”
SINGAPORE, Aug. 24, 2025 /PRNewswire/ — Golfin proudly announces the launch of the “MEXC Ventures Global Golf Masters supported by GOLFIN,” the... Read more.
UAB Qbit Financial Service Lawsuit Officially Dismissed by U.S. Court — Case Closed Without Findings of Wrongdoing
NEW YORK, Aug. 24, 2025 /PRNewswire/ — UAB Qbit Financial Service, a Lithuanian financial services provider, has recently issued an official clarification... Read more.
SBI Group and Chainlink Announce Strategic Partnership To Accelerate Institutional Digital Asset Adoption In Key Global Markets
SBI Group and Chainlink will power use cases related to tokenized real-world assets, tokenized funds, and regulated stablecoins, with an initial focus on the Japanese... Read more.
METABORA GAMES and Baligames to Participate in ‘WebX 2025’ and Showcase New Title ‘Puzzle & Guardians’
Core partner of LINE NEXT and Kaia DLT Foundation’s “Mini Dapp Station” at Japan’s largest Web3 conference Unveiling a new hybrid genre that... Read more.
Harbour BioMed Appoints Yajie Li as Chief Medical Officer
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Aug. 24, 2025 /PRNewswire/ — Harbour BioMed (the “Company”; HKEX: 02142), a global biopharmaceutical... Read more.
Innovent Biologics Announces U.S. FDA IND Approval for the First Global MRCT Phase 3 Study (MarsLight-11) of IBI363 (PD-1/IL-2α-bias) in Squamous Non-Small Cell Lung Cancer
SAN FRANCISCO and SUZHOU, China, Aug. 24, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical... Read more.